We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Conjugated Polymer Nanoparticles

Conjugated Polymer Nanoparticles  content piece image
Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Stream Bio, a company that develops and manufactures a range of bioimaging molecular probes, has announced the release of its Conjugated Polymer Nanoparticles (CPNs™).

Stream Bio’s CPNs have applications in diagnostics and therapeutics, with the potential to be used for imaging tumors and fluorescence-guided surgery. Highly fluorescent, non-toxic nanoparticles could transform the bioimaging market with their unique brightness, stability, magnetic capability and suitability for conjugation with a wide range of molecules.

Currently, CPNs are available in four wavelengths; 475nm, 510nm, 550nm and 680nm. They can also be purchased in a conjugated form, with fluorescent streptavidin covalently attached. This enables them to be used in different protocols for the detection of a variety of proteins, protein motifs, nucleic acids, and other biomolecules.

Initially, a small range of unconjugated CPNs will be available to purchase from Sigma Aldrich, with a wider range of products soon to be included in the listing.